Mounjaro: the version I wish someone had shown me in week 1
Mounjaro: the version I wish someone had shown me in week 1, logged the same way every week so the comparison is at least internally fair. The step schedule question, answered properly, because it comes up weekly. The label sets a minimum interval of four weeks between increases. That is a floor on how fast you may…
Switching from semaglutide, since three people asked in this thread alone.
There is no published dose equivalence between the two. The conversion tables that circulate are somebody’s arithmetic, not data. What people report here is that the first month after a switch is often flat, that the appetite effect feels differently shaped rather than simply stronger, and that starting at the bottom of the ladder again is the common approach.
None of that is a recommendation. It is what the threads say, and the threads are not a clinic.
Left up, flair changed to Discussion. It is an opinion post and that is fine as long as it is labelled.
Left up, flair changed to Discussion.
Agreed, with one qualifier: that is the mean of the top arm and the spread around it was enormous.
It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads. That is why the side-effect profile reads differently rather than just milder.
Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme. They are different endpoints and the numbers do not transfer.
12kg over 72 weeks, never went past 10mg, and early fullness stayed mild the whole way. Posting because the loud threads are all 15mg.
Pen or vial? The step sizes available differ and it changes this answer.